JKHY vs SNDX · P/E 30, rev $2.54B vs rev $137.7M
Jack Henry & Associates Inc (JKHY) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
JKHY currently screens at market cap $12.76B and trailing P/E 29.8. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the JKHY and SNDX stock pages for the full models.
Not investment advice.